2006
PGR +331 A/G and Increased Risk of Epithelial Ovarian Cancer
Risch HA, Bale AE, Beck PA, Zheng W. PGR +331 A/G and Increased Risk of Epithelial Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention 2006, 15: 1738-1741. PMID: 16985038, DOI: 10.1158/1055-9965.epi-06-0272.Peer-Reviewed Original ResearchConceptsOvarian cancerA allelePostmenopausal womenProgesterone receptor gene polymorphismHistologic tumor typePopulation-based studyEpithelial ovarian cancerEffect of progesteroneReceptor gene polymorphismsPremenopausal womenEndometrial cancerMenopausal statusOral contraceptivesOvarian neoplasiaProgesterone receptorProgestin exposureG genotypeGG genotypeGene polymorphismsTumor typesReceptor isoformsCancerWomenRiskProgesteroneMutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene
Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Human Mutation 2006, 27: 626-632. PMID: 16786505, DOI: 10.1002/humu.20339.Peer-Reviewed Original Research
1999
Mutational Analyses of Candidate Genes in Human Squamous Cell Carcinomas
Petroianu A, Boson W, Bale A, Friedman E, De Marco L. Mutational Analyses of Candidate Genes in Human Squamous Cell Carcinomas. The Laryngoscope 1999, 109: 661-663. PMID: 10201760, DOI: 10.1097/00005537-199904000-00027.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaCell carcinomaPolymerase chain reactionPrimary squamous cell carcinomaHuman squamous cell carcinomaEvidence of mutationsPresence of mutationsCommon malignancyUnselected populationCarcinomaStudy designMajor causeChain reactionPatientsCandidate genesPatched geneMolecular mechanismsTumorigenesisMutationsSequence alterationsMalignancyConformational polymorphismTumorsGenesMortality
1996
Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.
Shimkets R, Gailani M, Siu V, Yang-Feng T, Pressman C, Levanat S, Goldstein A, Dean M, Bale A. Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients. American Journal Of Human Genetics 1996, 59: 417-22. PMID: 8755929, PMCID: PMC1914731.Peer-Reviewed Original ResearchConceptsGorlin syndromeGorlin syndrome patientsSyndrome patientsMultiple basal cell carcinomasConductive hearing lossBasal cell carcinomaAllelic lossCancer predisposition syndromeAutosomal dominant disorderGerm-line deletionOvarian fibromaSecond patientCell carcinomaHearing lossGroup AGroup CPatientsSyndromeDominant mutationsSignificant phenotypic variabilityGorlin syndrome geneDominant disorderNull mutationXeroderma pigmentosum group AIdentical alterations
1995
REPORT on the Fourth International Workshop on Chromosome 9: held at Williamsburg, Virginia, USA, April 23–25, 1995
PERICAK‐VANCE M, BALE A, HAINES J, KWIATKOWSKI D, PILZ A, SLAUGENHAUPT S, WHITE J, EDWARDS J, MARCHUK D, OLOPADE O, ATTWOOD J, POVEY S. REPORT on the Fourth International Workshop on Chromosome 9: held at Williamsburg, Virginia, USA, April 23–25, 1995. Annals Of Human Genetics 1995, 59: 347-365. PMID: 8579331, DOI: 10.1111/j.1469-1809.1995.tb00756.x.Peer-Reviewed Original Research
1994
Fine Mapping of the Locus for Nevoid Basal Cell Carcinoma Syndrome on Chromosome 9q
Compton J, Kearns K, Bale S, Goldstein A, Turner M, Bale A, McBride O. Fine Mapping of the Locus for Nevoid Basal Cell Carcinoma Syndrome on Chromosome 9q. Journal Of Investigative Dermatology 1994, 103: 178-181. PMID: 8040607, DOI: 10.1111/1523-1747.ep12392682.Peer-Reviewed Original Research
1993
Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s).
Petty E, Gibson L, Fountain J, Bolognia J, Yang-Feng T, Housman D, Bale A. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). American Journal Of Human Genetics 1993, 53: 96-104. PMID: 8317504, PMCID: PMC1682234.Peer-Reviewed Original ResearchConceptsCutaneous malignant melanomaGerm-line deletionMalignant melanomaPrimary malignant melanomaMelanoma predisposition genePlexiform neurofibromaPulsed-field gel electrophoresisMultiple melanomasPredisposition genesMelanoma tumorigenesisMelanomaTandem repeat polymorphismCytogenetic rearrangementsPatient's DNAHigh-resolution karyotypeMode of inheritanceWomen
1991
The CEPH consortium linkage map of human chromosome 1
Dracopoli N, O'Connell P, Elsner T, Lalouel J, White R, Buetow K, Nishimura D, Murray J, Helms C, Mishra S, Donis-Keller H, Hall J, Lee M, King M, Attwood J, Morton N, Robson E, Mahtani M, Willard H, Royle N, Patel I, Jeffreys A, Verga V, Jenkins T, Weber J, Mitchell A, Bale A. The CEPH consortium linkage map of human chromosome 1. Genomics 1991, 9: 686-700. PMID: 2037294, DOI: 10.1016/0888-7543(91)90362-i.Peer-Reviewed Original ResearchHuman CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP.
Petersen D, McKinney C, Ikeya K, Smith H, Bale A, McBride O, Nebert D. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. American Journal Of Human Genetics 1991, 48: 720-5. PMID: 1707592, PMCID: PMC1682951.Peer-Reviewed Original ResearchOrnithine transcarbamylase polymorphism detected by PCR introduction of Dral site
Petty E, Carstens R, Bale A. Ornithine transcarbamylase polymorphism detected by PCR introduction of Dral site. Nucleic Acids Research 1991, 19: 690-690. PMID: 2011544, PMCID: PMC333689, DOI: 10.1093/nar/19.3.690.Peer-Reviewed Original Research
1990
Analysis of Gonadotropin-Releasing Hormone Gene Structure in Families with Familial Central Precocious Puberty and Idiopathic Hypogonadotropic Hypogonadism
NAKAYAMA Y, WONDISFORD F, LASH R, BALE A, WEINTRAUB B, CUTLER G, RADOVICK S. Analysis of Gonadotropin-Releasing Hormone Gene Structure in Families with Familial Central Precocious Puberty and Idiopathic Hypogonadotropic Hypogonadism. The Journal Of Clinical Endocrinology & Metabolism 1990, 70: 1233-1238. PMID: 2186053, DOI: 10.1210/jcem-70-5-1233.Peer-Reviewed Original Research
1989
Six RFLPs for human T cell receptor α (TCRA) on chromosome 14
Mitchell A, Bale A, Mak T, McBride O. Six RFLPs for human T cell receptor α (TCRA) on chromosome 14. Nucleic Acids Research 1989, 17: 2876-2876. PMID: 2566151, PMCID: PMC317684, DOI: 10.1093/nar/17.7.2876.Peer-Reviewed Original ResearchReport of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms pp. 622-643
Kidd KK, Bowcock AM, Schmidtke J, Track RK, Ricciuti F, Hutchings G, Bale A, Pearson P, Willard HF, Gelernter J, Giuffra L, Kubzdela K. Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms pp. 622-643. Cytogenetic And Genome Research 1989, 51: 622-643. PMID: 2676386, DOI: 10.1159/000132810.Peer-Reviewed Original ResearchMeSH KeywordsChromosome MappingCloning, MolecularDNAGenome, HumanGenomic LibraryHumansPolymorphism, Genetic
1988
A cDNA probe (PheA12) from the hc-(ERBA) gene on chromosome 3 detects a high frequency RFLP
Bale A, Usala S, Weinberger C, Weintraub B, McBride O. A cDNA probe (PheA12) from the hc-(ERBA) gene on chromosome 3 detects a high frequency RFLP. Nucleic Acids Research 1988, 16: 7756-7756. PMID: 2901070, PMCID: PMC338478, DOI: 10.1093/nar/16.15.7756.Peer-Reviewed Original ResearchA retinoic acid receptor cDNA probe (RAR2) identifies a moderately frequent RFLP on chromosome 17
Bale A, Weinberger C, McBride O. A retinoic acid receptor cDNA probe (RAR2) identifies a moderately frequent RFLP on chromosome 17. Nucleic Acids Research 1988, 16: 7755-7755. PMID: 2901069, PMCID: PMC338477, DOI: 10.1093/nar/16.15.7755.Peer-Reviewed Original Research